Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer’s disease continuum

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer’s disease continuum ; volume:15 ; number:1 ; day:28 ; month:10 ; year:2023 ; pages:1-13 ; date:12.2023
Alzheimer's research & therapy ; 15, Heft 1 (28.10.2023), 1-13, 12.2023

Classification
Medizin, Gesundheit

Creator
Goossens, Julie
Cervantes González, Alba
Dewit, Nele
Lidón, Laia
Fortea, Juan
Alcolea, Daniel
Lleó, Alberto
Belbin, Olivia
Vanmechelen, Eugeen
Contributor
SpringerLink (Online service)

DOI
10.1186/s13195-023-01336-0
URN
urn:nbn:de:101:1-2024011608415799747171
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:31 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Goossens, Julie
  • Cervantes González, Alba
  • Dewit, Nele
  • Lidón, Laia
  • Fortea, Juan
  • Alcolea, Daniel
  • Lleó, Alberto
  • Belbin, Olivia
  • Vanmechelen, Eugeen
  • SpringerLink (Online service)

Other Objects (12)

The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer’s disease

The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer’s disease

Transcriptomic profiling of sporadic Alzheimer’s disease patients

Transcriptomic profiling of sporadic Alzheimer’s disease patients

Notch1 hallmarks fibrillary depositions in sporadic Alzheimer’s disease

Notch1 hallmarks fibrillary depositions in sporadic Alzheimer’s disease

Importance of extracellular vesicle secretion at the blood–cerebrospinal fluid interface in the pathogenesis of Alzheimer’s disease

Importance of extracellular vesicle secretion at the blood–cerebrospinal fluid interface in the pathogenesis of Alzheimer’s disease

Modelling Sporadic Alzheimer’s Disease Using Induced Pluripotent Stem Cells

Modelling Sporadic Alzheimer’s Disease Using Induced Pluripotent Stem Cells

Distinct cerebrospinal fluid amyloid β peptide signatures in sporadic and PSEN1A431E-associated familial Alzheimer's disease

Distinct cerebrospinal fluid amyloid β peptide signatures in sporadic and PSEN1A431E-associated familial Alzheimer's disease

Erratum to: Notch1 hallmarks fibrillary depositions in sporadic Alzheimer’s disease

Erratum to: Notch1 hallmarks fibrillary depositions in sporadic Alzheimer’s disease

CDiP technology for reverse engineering of sporadic Alzheimer’s disease

CDiP technology for reverse engineering of sporadic Alzheimer’s disease

VAMP-2 is a surrogate cerebrospinal fluid marker of Alzheimer-related cognitive impairment in adults with Down syndrome

VAMP-2 is a surrogate cerebrospinal fluid marker of Alzheimer-related cognitive impairment in adults with Down syndrome

Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease

Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease

Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease

Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease

N-truncated Aβ4–x peptides in sporadic Alzheimer’s disease cases and transgenic Alzheimer mouse models

N-truncated Aβ4–x peptides in sporadic Alzheimer’s disease cases and transgenic Alzheimer mouse models

Related objects